Publication
Epithelial N-methyl-D-aspartate (NMDA) receptors mediate renal vasodilation by affecting kidney autoregulation
Downloadable Content
- Persistent URL
- Last modified
- 01/14/2026
- Type of Material
- Authors
- Language
- English
- Date
- 2023-12-06
- Publisher
- NIH
- Publication Version
- Copyright Statement
- The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- Start Page
- 569973
- Grant/Funding Agency
- National Institute of Health
- Grant/Funding Information
- This work was supported by the National Institute of Health NHLBI Grant K01HL155235 to C.R., and a developmental grant from the NIH-Funded Emory Specialized Center of Research Excellence in Sex Differences U54AG062334 to C.R. Supported by R01 DK-110409 to D.C.E, K01 DK-115660 and ASN Gottschalk AWARD to B.M.W, and R01 DK- 119793 to S.M.W.
- Abstract
- Background: N-methyl-D-aspartate receptor (NMDAR) are amino acid receptors that are well studied in brain physiology; however, their role in kidney is poorly understood. Nonetheless, NMDAR inhibitors can increase serum K+ and reduce GFR, which suggests they have an important physiological role in the kidney. We hypothesized that NMDARs in the distal nephron induce afferent-arteriole vasodilation through the vasodilator mechanism connecting-tubule-glomerular feedback (CNTGF) that involves ENaC activation. Methods and results: Using a tubule-specific transcriptome database combined with molecular biology and microscopy techniques, we showed kidney expression of NMDAR subunits along the nephron and specifically in ENaC-positive cells. This receptor is expressed in both male and female mice, with higher abundance in females (p=0.02). Microperfusing NMDAR agonists into the connecting tubule induced afferent-arteriole vasodilation (EC50 10.7 vs. 24.5 mM; p<0.001) that was blunted or eliminated with the use of NMDAR blocker MK-801 or with the ENaC inhibitor Benzamil, indicating a dependence on CNTGF of the NMDAR-induced vasodilation. In vivo, we confirmed this CNTGF-associated vasodilation using kidney micropuncture (Stop-flow pressure 37.9±2.6 vs. 28.6±1.9 mmHg, NMDAR agonist vs vehicle; p<0.01). We explored NMDAR and ENaC channel interaction by using mpkCCD cells and split-open connecting tubules. We observed increased amiloride-sensitive current following NMDAR activation that was prevented by MK-801 (1.14 vs. 0.4 μAmp; p=0.03). In split-open tubules, NMDAR activation increased ENaC activity (Npo Vehicle vs. NMDA; p=0.04). Conclusion: NMDARs are expressed along the nephron, including ENaC-positive cells, with higher expression in females. Epithelial NMDAR mediates renal vasodilation through the connecting-tubule-glomerular feedback, by increasing ENaC activity.
- Author Notes
- Keywords
- Subject - Topics
- Physiology
- Kidney
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Epithelial N-methyl-D-aspartate (NMDA) receptors mediate renal vasodilation by affecting kidney autoregulation | Primary Content | 2025-10-29 | Public | Download |